1. http://table.finance.yahoo.com/d?a=3&b=22&c=01&d=3&e=22&f=01&g=d&s=imnx (accessed on 25/06/02).
2. http://table.finance.yahoo.com/d?a=3&b=23&c=01&d=3&e=23&f=01&g=d&s=imnx (accessed on 25/06/02).
3. IHFS: Etanercept No Benefit in Treating Heart Failure – International Study Stopped Prematurely. – http://www.pslgroup.com/dg/2001d6.htm (accessed on 25/06/02).
4. McMurray J, Mann DL. Effects of cytokine antagonism with etanercept on morbidity and mortality in chronic heart failure: results of the randomized etanercept world-wide evaluation (RENEWAL) trial. Hot Line Session. Oral presentation, Oslo/Norway, 10th June, 2002.
5. Packer M. A phase II, multicenter, randomized, double-blind, placebo-controlled pilot trial evaluating the effects of infliximab (Remicade) in patients with stable class III or IV congestive heart failure (“ATTACH”). Hot Line Session. Oral presentation, Oslo/Norway, 10th June, 2002.